COVID-19 Video Updates, 102-104

Post Overview
    Add a header to begin generating the table of contents


    Our most recent additions to the COVID-19 Explained Clearly series cover the latest updates on clinical trials and treatments, reinfection and immunity, news on the use of convalescent plasma, and more. In addition, we recorded multiple short Q/A videos with Dr. Michael Mina about COVID-19 testing and vaccines. 


    COVID-19 vs. Influenza Symptoms; Sweden; Tocilizumab; Hawaii

    In our 102nd COVID-19 update, Dr. Seheult discusses this article on Sweden’s ability to flatten the curve to some degree (and keep it that way). In contrast, daily new cases have risen in Hawaii even with a mandated 14-day quarantine for anyone traveling there from out of state or island to island. 

    Dr. Seheult also talks about therapy and treatment for COVID-19, giving an update on Actemra (or tocilizumab). The COVACTA trial (double-blinded, randomized, placebo-controlled) released preliminary data on its study of tocilizumab treatment of pneumonia associated with COVID-19. Tocilizumab was not found to improve the clinical status nor reduce mortality in the COVID-19 patients studied. Regarding COVID-19 symptoms compared to influenza symptoms, this study published on Frontiers in Public Health mapped the onset of symptoms for each infection, providing potentially vital information to help doctors navigate care for patients as we approach flu season. 


    Convalescent Plasma Treatment & the FDA; College Campuses Close

    In our 103rd video update on COVID-19, Dr. Seheult talks about the impact on higher education, citing the University of North Carolina’s decision to suspend in-person classes just one week after reopening campus. Dr. Seheult also shares updates on treating COVID-19 patients with convalescent plasma, citing a few preliminary studies before diving into this pre-print study from the Mayo Clinic. Because there was no control group, this study has limitations, and the FDA announced that authorization of blood plasma for COVID-19 was on hold due to a lack of data.


    COVID-19 Reinfection & Immunity

    In our 104th COVID-19 update video, Dr. Seheult dives into this report of the first COVID-19 reinfection case in Hong Kong. He discusses potential explanations for this patient’s asymptomatic second SARS-CoV-2 diagnosis, after being hospitalized and making a full recovery about four months prior. Shortly after the news of this patient’s reinfection, two other cases in Belgium and the Netherlands were reported. Dr. Seheult then shares input from Dr. Michael Mina on building immunity through reinfection.


    Stay Tuned for More COVID-19 Updates

    Our COVID-19 videos are always available and free (and ad-free) at In addition, check out our full library of courses and lectures on subjects ranging from Acute Abdominal Pain to Board Questions Explained Clearly and many more!

    Meanwhile, here’s a list of all the COVID-19 resources we’ve shared so far:

    1 Comment

    1. Manuel Rivera on November 30, 2020 at 11:06 am

      My son-in-law got Covid-19 and after 2 clinic visits went to ED with pulse ox 88-90%. Treated with ABX (rocephin), IVF, steroids,Remdesivir, and plasma. Got better and went home. Meanwhile my daughter came down with it and again after 2 clinic visits, was sent to ED. Pulse ox 94%. Treated with steroids and IVF. CXR Left infiltrate. Sent home. She is wondering if she can reinfect her husband even though he just got out of the hospital. Can there be reinfection that soon after treatment and presumed “cure”? Thank you.
      M Rivera, M.D>

    Leave a Comment